3 biotech investment trends gleaned from JP Morgan conference
Pharma is warming up to innovation, personal medicine — particularly for oncology — is hot and molecular diagnostics have moved from the bench to the bedside. As bullish as investors seem about biotech investments, how long is that likely to last? Those were some of the talking points at the JP Morgan Healthcare conference where […]